Currently Viewing:
Supplements Impact of Obesity Interventions on Managed Care
Obesity: Definition, Comorbidities, Causes, and Burden
Caroline M. Apovian, MD, FACP, FACN
Overweight and Obesity Management Strategies
Scott Kahan, MD, MPH
The Role of Managed Care Organizations in Obesity Management
Kenneth L. Schaecher, MD, FACP, CPC
Currently Reading
Impact of Obesity Interventions on Managed Care

Impact of Obesity Interventions on Managed Care

Publishing Staff
Senior Vice President of Operations and Clinical Affairs
Jeff D. Prescott, PharmD, RPh
Senior Clinical Projects Manager
Ida Delmendo
Clinical Projects Manager
Cindy Spielvogel
Project Manager
Jessica Toye
Proofreaders
Griselda Demassey
Maggie Shaw
Associate Editor
Jeanne Linke
Assistant Editor
Sarah Anwar
Clinical Editor
Michael R. Page, PharmD, RPh
Designer
Julianne Costello
Associate Publisher
Justin T. Gallagher
Director of Sales
Sara Belanger
National Account Managers
Gabrielle Consola
Michael Costella
 
Corporate
Chairman and CEO
Mike Hennessy, Sr
Vice Chairman
Jack Lepping
President
Mike Hennessy, Jr
Chief Operating Officer/CFO
Neil Glasser, CPA/CFE
President, Managed Markets, Pharmacy, and Rare Disease
Brian Haug
Executive Vice President and General Manager
John Maglione
Chief Creative Officer
Jeff Brown
Human Resources Director
Shari Lundenberg
President, Pharmacy Times Continuing Education
David Heckard

PARTICIPATING FACULTY
 
Caroline M. Apovian, MD, FACP, FACN
Director
Nutrition and Weight Management Center
Boston Medical Center
Professor of Medicine and Pediatrics
Boston University School of Medicine
Boston, Massachusetts
 
Scott Kahan, MD, MPH
Medical Director
Strategies to Overcome and Prevent (STOP) Obesity Alliance
George Washington University
Director
National Center for Weight and Wellness
Washington, DC
 
Kenneth L. Schaecher, MD, FACP, CPC
Medical Director
SelectHealth
Salt Lake City, Utah

Editorial Support
Jill E. Allen, PharmD
Drug Information Consultant
Pin Oak Associates
Salt Lake City, Utah
 
Christine Sokoloski, MS
Medical Writer
Hillsborough, New Jersey
 
Jeannette Y. Wick, RPh, MBA, FASCP
Visiting Professor
University of Connecticut School of Pharmacy
Storrs, Connecticut

Faculty Disclosures
Caroline M. Apovian, MD, FACP, FACN, has the following relevant financial relationships with commercial interests to disclose:
 
Consultant:
Amylin, Arena, EnteroMedics, Gelesis, Johnson and Johnson, Merck, Novo Nordisk, Nutrisystem, Orexigen, Sanofi-Aventis, Scientific Intake, Takeda, Zafgen
 
Research Funding:
Amylin, Aspire Bariatrics, the Dr. Robert C. and Veronica Atkins Foundation, GI Dynamics, Lilly, MetaProteomics, MYOS Corporation, Orexigen, Pfizer, Sanofi-Aventis

Stock:
Science Smart LLC
 
Scott Kahan, MD, MPH, has the following relevant financial relationships with commercial interests to
disclose:

Board Membership:
American Board of Obesity Medicine

Consultant:
Novo Nordisk, Orexigen, Takeda, Vivus

Kenneth L. Schaecher, MD, FACP, CPC, has no relevant financial relationships with commercial
interests to disclose.
 
  • Editorial Support Disclosures
Jill E. Allen, PharmD; Christine Sokoloski, MS; and Jeannette Wick, RPh, MBA, FASCP, have no
relevant financial relationships with commercial interests to disclose.

The American Journal of Managed Care
Publishing Staff—Jeff D. Prescott, PharmD, RPh; Ida Delmendo; and Cindy Spielvogel have no relevant
financial relationships with commercial interests to disclose.
 
Pharmacy Times Continuing Education
Planning Staff—Dave Heckard; Maryjo Dixon, RPh; Dipti Desai, PharmD, RPh; Beatriz Manzor Mitrzyk,
PharmD, BCPS; Donna Fausak; Nathalie Harden; and Tara DeLorenzo have no relevant financial
relationships with commercial interests to disclose.
 
Disclosure Policy
According to the disclosure policy of The American Journal of Managed Care and Pharmacy Times Continuing Education, all persons who are in a position to control content are required to disclose any relevant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of Pharmacy Times Continuing Education to initiate a mechanism to resolve the conflict(s). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
 
Disclosure of Unapproved/Off-Label Use
The contents of this activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Participants should note that the use of these products outside current approved labeling is considered experimental and
are advised to consult prescribing information for these products. 
 
The information provided in this CE activity is for continuing medical and pharmacy education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of The American Journal of Managed Care, Pharmacy Times Continuing Education, or any of the companies that provided commercial support for this CE activity.

 
PDF
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up